Pelagos Insurance Capital (PLGO) Combined Ratio Of 86.6% Tests Bearish Earnings Narratives

Pelagos Insurance Capital Limited

Pelagos Insurance Capital Limited

PLGO

0.00

Pelagos Insurance Capital (PLGO) opened 2026 with Q1 revenue of US$610.6 million and basic EPS of US$1.16. Trailing twelve month revenue was US$2.45 billion with EPS of US$3.70, framing a period where the company has moved from losses into consistent profitability over the past year. Over recent quarters, revenue has ranged between US$589.3 million and US$673.8 million, while quarterly EPS has shifted from a loss of US$1.09 in Q4 2024 to positive readings across 2025 and into 2026. This provides a clearer view of how profits have been rebuilt. With the latest quarter supported by a combined ratio of 86.6%, the focus this season is on how improving underwriting margins shape the investment case.

See our full analysis for Pelagos Insurance Capital.

With the headline numbers on the table, the next step is to see how these results line up with the prevailing narratives around Pelagos Insurance Capital's growth, risks, and profitability story.

NYSE:PLGO Revenue & Expenses Breakdown as at May 2026
NYSE:PLGO Revenue & Expenses Breakdown as at May 2026

Combined ratio shift from 115.6% to 86.6%

  • Pelagos moved from a combined ratio of 115.6% and a loss of US$42.5 million in Q1 2025 to a combined ratio of 86.6% with net income of US$108 million in Q1 2026, showing a very different underwriting outcome over 12 months.
  • Bulls highlight that better risk selection and analytics should support stronger underwriting over time, and this recent run of positive combined ratios below 100% in 3 of the last 4 quarters:
    • Q3 2025 showed a combined ratio of 79% alongside net income of US$130.5 million, while Q4 2025 did not disclose a combined ratio but still produced US$117.8 million of net income.
    • Across the latest trailing 12 months, Pelagos earned US$376 million versus losses recorded a year earlier, which heavily supports the bullish view that underwriting quality and earnings quality have improved since the loss making periods.
Consistent underwriting and earnings are exactly what bullish investors point to as the foundation for a stronger long term story, and the latest combined ratio progression gives them more to talk about. 🐂 Pelagos Insurance Capital Bull Case

TTM EPS of US$3.70 on a 5.3x P/E

  • On a trailing 12 month basis to Q1 2026, Pelagos reported EPS of US$3.70 and net income of US$376 million, which at a share price of US$23.46 equates to a P/E of 5.3x, well below the cited US insurance industry average of 10.8x and peer average of 10.7x.
  • What stands out for the bearish camp is the tension between this low multiple and earnings forecasts that are expected to decline by about 2.6% per year over the next three years:
    • Reported earnings over the past five years declined at an annualized rate of 39.1%, so bears argue that a single profitable year and a low P/E at US$23.46 do not, on their own, resolve concerns about the durability of those earnings.
    • With revenue projected to grow at 8.9% per year, slower than the 11.6% forecast for the wider US market, skeptics see the current 5.3x P/E as reflecting caution about future earnings rather than a simple mispricing.
Skeptical investors will want to see whether future reports keep backing this new earnings level or if the cautious view starts to gain the upper hand. 🐻 Pelagos Insurance Capital Bear Case

DCF fair value far above US$23.46

  • The supplied DCF fair value of US$135.22 sits well above the current share price of US$23.46, while trailing 12 month net income of US$376 million and EPS of US$3.70 indicate that the business was profitable over the last year despite earlier periods of losses.
  • Consensus narrative points out that analysts see revenue growing at 8.2% per year with margins rising from 9.0% to 10.6%, which contrasts with the separate forecast of a 2.6% annual earnings decline:
    • These differing outlooks mean investors are weighing a large gap to the US$135.22 DCF fair value against mixed expectations on future profit growth, all while the stock trades on a 5.3x P/E at US$23.46.
    • The trailing 12 month turnaround from a reported loss of US$14.5 million at Q3 2025 to net income of US$376 million by Q1 2026 illustrates why some see upside potential if that profitability can be sustained, even as others focus on the multi year earnings decline of 39.1% per year.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Pelagos Insurance Capital on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With all of this in mind, do the current numbers make Pelagos look more promising or more fragile to you, and how urgent does that feel? Take a closer look at the data, weigh both sides of the story for yourself, and check out the 3 key rewards and 1 important warning sign

See What Else Is Out There

Pelagos carries a low 5.3x P/E alongside mixed earnings forecasts and a history of multi year earnings decline of 39.1% per year, which keeps some investors cautious.

If that earnings track record makes you uneasy, you may wish to balance your watchlist by checking out 67 resilient stocks with low risk scores so you can focus on companies with steadier profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.